Vault-13

Aquilo Capital Management, LLC

SAN FRANCISCO, CA · CIK 1591986 · 13F filing filed 2025-05-15

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$37.1m reported value -36.5% vs Q4 2024
12positions
93.8%in top 10
1 new 3 added 7 reduced 2 sold out vs Q4 2024

Options: 1 call positions ($18.7m notional), 0 put positions (— notional) – listed below, not included above.

Holdings, Q1 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 BLUEPRINT MEDICINES CORP COM BPMC BPMC 83,926 $7.4m20.03% 20.03% ReducedShares held: Q2 2024 114.6k, Q3 2024 124.6k, Q4 2024 129.6k, Q1 2025 83.9k -45.7k -45,674 -35.2%
2 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 550,130 $7.0m18.90% 18.90% ReducedShares held: Q2 2024 908.5k, Q3 2024 795.8k, Q4 2024 707.6k, Q1 2025 550.1k -157.5k -157,459 -22.2%
3 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 81,692 $4.0m10.65% 10.65% AddedShares held: Q2 2024 0, Q3 2024 0, Q4 2024 76.6k, Q1 2025 81.7k +5.1k +5,100 6.7%
4 KYMERA THERAPEUTICS INC COM KYMR KYMR 138,521 $3.8m10.22% 10.22% ReducedShares held: Q2 2024 328.7k, Q3 2024 208.7k, Q4 2024 183.5k, Q1 2025 138.5k -45.0k -45,000 -24.5%
5 PRECISION BIOSCIENCES INC COM NEW DTIL DTIL 726,149 $3.5m9.34% 9.34% AddedShares held: Q2 2024 381.8k, Q3 2024 381.8k, Q4 2024 536.4k, Q1 2025 726.1k +189.8k +189,773 35.4%
6 ARVINAS INC COM ARVN ARVN 360,766 $2.5m6.83% 6.83% AddedShares held: Q2 2024 428.8k, Q3 2024 388.8k, Q4 2024 328.8k, Q1 2025 360.8k +32.0k +32,000 9.7%
7 REGENXBIO INC COM RGNX RGNX 271,302 $1.9m5.23% 5.23% ReducedShares held: Q2 2024 906.2k, Q3 2024 930.7k, Q4 2024 346.3k, Q1 2025 271.3k -75.0k -75,000 -21.7%
8 ADICET BIO INC COM COM 2,456,194 $1.9m5.00% 5.00% ReducedShares held: Q2 2024 2.5m, Q3 2024 2.5m, Q4 2024 2.5m, Q1 2025 2.5m -75.0k -75,000 -3.0%
9 BICYCLE THERAPEUTICS PLC SPONSORED ADS BCYC BCYC 171,695 $1.5m3.93% 3.93% ReducedShares held: Q2 2024 156.7k, Q3 2024 181.9k, Q4 2024 221.9k, Q1 2025 171.7k -50.2k -50,216 -22.6%
10 IMMATICS N.V SHS IMTX IMTX 304,902 $1.4m3.71% 3.71% ReducedShares held: Q2 2024 200.0k, Q3 2024 333.5k, Q4 2024 373.9k, Q1 2025 304.9k -69.0k -69,000 -18.4%
11 REPARE THERAPEUTICS INC COM RPTX RPTX 1,293,715 $1.3m3.44% 3.44% UnchangedShares held: Q2 2024 956.9k, Q3 2024 989.4k, Q4 2024 1.3m, Q1 2025 1.3m
12 ZYMEWORKS INC COM ZYME ZYME 84,482 $1.0m2.71% 2.71% NewShares held: Q2 2024 0, Q3 2024 0, Q4 2024 0, Q1 2025 84.5k

Sold out since Q4 2024

SecurityTickerShares held beforeValue then
SILENCE THERAPEUTICS PLC SLN SLN 367,214 $2.5m367.2k shares
SUTRO BIOPHARMA INC 498 $916498 shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
AMGEN INC AMGN · Call AMGNCall 60,000 $18.7m60.0k shares Added